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Letters to the Editor
Reversible  posterior  leukoencephalopathy  syndrome:  a
recurrent and atypical  case  in hemodialysisLeucoencefalopatía  posterior  reversible:  un  caso  recurrente  y  atípico
Table 1 – Differential diagnosis of RPLS.
Vascular disease Non-vascular disease
Cerebral venous sinus
thrombosis
Infectious encephalitis
Intracranial hemorrhage Autoimmune encephalitis
Posterior circulation stroke Metabolic/toxic encephalopathy
was  transferred to ICU. An MRI was ordered and the ﬁndingsen  hemodiálisis
To the Editor,
Reversible posterior leukoencephalopathy syndrome (RPLS)
is a clinical and radiological syndrome described in 1996.
Its pathogenesis is still unclear and there are two theories:
(1) cerebral hyperperfusion and (2) severe vasospasm.1–3 It
is associated with malignant hypertension, eclampsia and
other coexisting conditions in patients with chronic kidney
disease (CKD) such as hypertension, vascular or autoimmune
diseases, as well as immunosuppressants, erythropoietin and
transplantation.2
A higher number of cases have been described in women.
Clinical symptoms include seizures (93%), visual distur-
bances (67%), loss of consciousness (53%) and headache (47%).
Between 7 and 13% present aphasia, hemiplegia, hemiparesis
or mental impairment.1
In 2010, a large case series (113 adults) was published,
among which only 6% were recurrent4: from 2 weeks to 36
months after the initial episode.4,5
Cranial MRI  is the gold standard; it shows symmetrical
parieto-occipital white matter abnormalities (cortical or sub-
cortical edema), which are reversible after days or weeks of
treatment.1–5
Only a fast and adequate control of triggering events
prevents irreversible complications. Sometimes antiepilep-
tics, general anesthesia and mechanical ventilation must
be administered; it has not yet been conﬁrmed that corti-
costeroids reduce vascular edema.2 There is no association
between the severity of hypertension and the sequelae.5
In the differential diagnosis, multiple diseases should be
considered2 (Table 1).
We  describe a case that we ﬁnd interesting because of its
unusual clinical presentation and subsequent recurrence:
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RPLS: reversible posterior leukoencephalopathy syndrome.
34-year-old male, on HD with CKD secondary to obstruc-
tive uropathy (verumontanum). His hypertension was treated
with atenolol 50 mg/day. He presented to the emergency
department for aphasia and agitation. Fever (38.8 ◦C), BP:
232/124 mmHg. No signiﬁcant ﬁndings on physical exami-
nation. Blood count: normal leukocytes, slight neutrophilia
and lymphopenia. Normal cranial CT and lumbar punc-
ture. Negative blood and CSF cultures, and negative serology.
Ocular fundus: hypertensive retinopathy grade III. He was
hospitalized to Infectious Disease Service for suspected
meningoencephalitis; empirical treatment was initiated with
ampicillin, vancomycin, acyclovir, rifampicin and isoniazid.
It remained difﬁcult to control the blood pressure (SBP:
150–200 mmHg, DBP: 90–120 mmHg); this was initially treated
with labetalol via infusion pump, ACE inhibitors and calcium
antagonists, but oral minoxidil 10 mg  and atenolol 100 mg  and
adjustment of dry weight were also needed.
As a result of progressive reduction in the level of con-
sciousness, reaching a score of 4 on the Glasgow scale, heún˜ez-García JM, Aller-Aparicio C, Sanz-Ballesteros S, Mendiluce-
y atípico en hemodiálisis. Nefrología. 2016;36:192–193.
suggested RPLS: bilateral parieto-occipital subcortical white
matter hyperintensity in T2 and FLAIR weighted sequences.
Ten days later, the follow-up MRI  was normal (Fig. 1).
n e f r o l o g i a. 2 0 1 6;3  6(2):192–199 193
Fig. 1 – Cranial MRI  ﬁndings: (A) bilateral parieto-occipital subcortical white matter hyperintensity; (B) follow-up MRI  after 10
d RI  co
a
R
a
s
(
I
a
p
a
1
4
a
e
c
o
m
a
i
i
r
1
2
3
4
5ays of treatment, with complete resolution of lesions; (C) M
After 22 days in ICU, no neurological sequelae were present
nd he was transferred to Nephrology with a diagnosis of
PLS, probably hypertensive. Antihypertensive therapy was
djusted at discharge to maintain SBP at ≤150 mmHg.
Six months later he was readmitted for right hemipare-
is and dysarthria secondary to hypertensive emergency
280/120 mmHg), with normal cranial CT. He was admitted to
CU with decreased level of consciousness, motor agitation
nd poor BP control. The MRI  showed similar changes in the
revious location, conﬁrming recurrent RPLS in the context of
 hypertensive emergency.
Pharmacological treatment was optimized with irbesartan
50 mg  (0–0–1), carvedilol 25 mg  (1/2–0–1/2), Carduran neo®
 mg  (1–0–1), and enalapril 20 mg (1/2–0–1/2).
This is a rare case because it is a male who began with fever
nd neurological disturbances in the context of hypertensive
mergency, and had a recurrence after 6 months.
In the literature, hypertensive crises, CKD and sudden
hanges in pressure and volume in HD are related as triggers
f disease recurrence.5 Early diagnosis through MRI  and treat-
ent of risk factors, in this case controlling the blood pressure,
re essential for reversing the clinical picture and prevent-
ng recurrence. If it persists, it can be fatal or it may result
n serious neuropsychological sequelae.
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